“…The matrix effects for doxorubicin, doxorubicinol, doxorubicinone, doxorubicinolone, 7-deoxydoxorubicinone, and daunorubicin (IS) were 112.9-119.7%, 94.8-109.6%, 105.1-117.9%, 99.0-111.0%, 98.3-108.3%, and 88.0%, respectively, with RSD ≤ 14.2% at low, medium, and high QC levels (Table 2), indicating the presence of a small matrix effect. Liquid−liquid extraction using chloroform:methanol (4:1, v/v) resulted in higher sensitivity and smaller matrix effects for doxorubicin and its four metabolites compared with the protein precipitation method using methanol, acetonitrile, or acetone [13][14][15]18,19,21,22,[25][26][27]31,32,34,35]. Our method yielded LLOQ levels of doxorubicin (0.5 ng/mL) and its major four metabolites (0.1-0.01 ng/mL) that were better than those reported using the least plasma volume of 10 µL.…”